This study is designed as a long-term extension to Study APL2-C3G-310, and is being conducted to establish the long-term safety and efficacy of pegcetacoplan in patients with C3 glomerulopathy (C3G) or immune-complex membranoproliferative…
- Investigator
- Lawrence R Shoemaker
- Status
- Accepting Candidates
- Ages
- 12 Years - N/A
- Sexes
- All